Loading insider details...
Latest Form 4 (Feb 3, 2026): Disposition to Issuer of 22,500 APLT shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 3, 2026 | Applied Therapeutics, Inc. (APLT) | Disposition to Issuer | 22,500 | n/a |
| Dec 18, 2025 | SAB Biotherapeutics, Inc. (SABS) | Grant/Award | 150,000 | n/a |
| Jun 11, 2025 | Applied Therapeutics, Inc. (APLT) | Grant/Award | 200,000 | n/a |
| Jul 17, 2024 | SAB Biotherapeutics, Inc. (SABS) | Grant/Award | 20,000 | n/a |
| Jun 7, 2024 | Applied Therapeutics, Inc. (APLT) | Grant/Award | 45,000 | n/a |
| Jun 9, 2023 | Applied Therapeutics Inc. (APLT) | Grant/Award | 20,000 | n/a |
| May 22, 2023 | DEXCOM INC (DXCM) | Gift | 3,876 | n/a |
| Aug 5, 2022 | Applied Therapeutics Inc. (APLT) | Disposition to Issuer | 16,500 | n/a |
| Jun 8, 2022 | Applied Therapeutics Inc. (APLT) | Grant/Award | 16,500 | n/a |
| May 23, 2022 | DEXCOM INC (DXCM) | Other (see footnotes) | 900 | n/a |